<DOC>
	<DOCNO>NCT02512536</DOCNO>
	<brief_summary>Rotator cuff arthropathy cause shoulder arthritis common condition see primary secondary care . It painful condition , significant disability . Specialist shoulder replacement find acceptance within trust , nationally internationally although high complication rate . There however significant cost difference ( fifty fold ) reverse total shoulder replacement botox injection , date randomise control trial , register , compare use botox injection pain relief cuff arthropathy versus treatment . If significant clinical difference pain outcomes two , could result significant saving NHS taxpayer whole . If high level pain relief could predictably obtain use Botulinum A toxin injection potentially patient could avoid need surgery .</brief_summary>
	<brief_title>Does Botulinum A Toxin Help With Pain From Rotator Cuff Arthropathy ?</brief_title>
	<detailed_description>Null Hypothesis This pilot / feasability study . The null hypothesis effect pain oxford shoulder score report patient receive target botulinum A toxin injection presence cuff arthropathy 6 week , 3 month 6 month compare baseline value . Objectives The aim feasability study provide necessary information planning future trial . It test feasibility run trial provide estimate differences outcome measure information resource data . All potential participant study identify Orthopaedic Shoulder Consultant shoulder clinic run Royal Devon Exeter NHS Trust . The patient screen eligibility research associate ( SG ) . The eligibility criteria patient medically fit operation , painful rotator cuff arthropathy , deem suitable intervention consultant surgeon . The patient inform verbally write trial research associate inform consent take . The participate patient allocate USS guide botox injection . All patient ask complete number questionnaire prior injection : Oxford Shoulder Score ( OSS ) , Visual Analogue Score ( VAS ) EQ-5D . The range movement shoulder joint document usual fashion . The injection do Dr Anaspure ( Consultant Radiologist ) USS guidance standard manner . After injection , patient review use range movement , OSS , patient satisfaction score EQ-5D 6 week , 3 month 6 month post injection . A record kept complication associate treatment . This data collect research associate , independent either intervention .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Inclusion criterion The eligibility criterion participation study patient medically fit operation diagnose symptomatic rotator cuff arthropathy . They must able give informed consent evidence cuff arthropathy plain radiograph affect shoulder . Exclusion criterion Contraindications surgery ( define severe cardiac impairment , e.g . heart valve replacement , arrhythmia , previous myocardial infarction ; severe respiratory impairment , e.g . chronic obstructive pulmonary disease , asthma require hospital admission ; systemic medical condition would produce specific contraindication general anaesthetic ) . Evidence patient would unable adhere trial procedure complete questionnaire , dementia intravenous drug abuse Note : If recruit patient require contralateral shoulder botox injection trial period , second shoulder include study since result intervention would independent first intervention . Other exclusion criterion include : Previous fracture dislocation shoulder . Previous surgery affect shoulder . Any neurological medical condition result spasticity</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>